Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01727505
Other study ID # 20120623
Secondary ID
Status Completed
Phase N/A
First received November 8, 2012
Last updated November 18, 2015
Start date November 2012
Est. completion date November 2015

Study information

Verified date November 2015
Source University of Miami
Contact n/a
Is FDA regulated No
Health authority United States: Data and Safety Monitoring BoardUnited States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Preterm infants undergoing mechanical ventilation often present with respiratory instability which leads to fluctuations in ventilation and oxygenation. In conventional modes of mechanical ventilation used in these patients, the ventilator delivers breaths at a set rate and a constant peak inspiratory pressure.

We have demonstrated that spontaneous episodes of hypoxemia in mechanically ventilated preterm infants are frequently triggered by a loss in end-expiratory lung volume followed by decrease in tidal volume. This is due to a reduction in respiratory system compliance and increase in airway resistance.

Volume Guarantee ventilation is a mode of ventilation in which ventilator measures the exhaled tidal volume of each ventilator breath and automatically adjusts the peak inspiratory pressure to deliver the set tidal volume. We have previously shown that Volume Guarantee reduced the severity and duration of hypoxemia episodes during a period of 2 hours in preterm infants The study hypothesis is that Volume Guarantee ventilation will decrease the duration of episodes of hypoxemia when compared to conventional mechanical ventilation during routine clinical conditions and over longer periods of time.

The objective of the study is to evaluate the effects of Volume Guarantee on the duration, severity and frequency of episodes of hypoxemia in mechanically ventilated preterm infants who present with frequent hypoxemia episodes in comparison to conventional ventilation over two periods of 24 hours each and under routine clinical conditions.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date November 2015
Est. primary completion date November 2015
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Born at less than 32 weeks of gestational age.

- Requiring mechanical ventilation on a mandatory ventilator rate greater than or equal to 20 per minute and receiving a mean tidal volume of at least 4 ml/kg.

- Presenting with 4 or more episodes of hypoxemia, defined as oxygen saturation less than 75%, in the 8 hours prior to the study.

Exclusion Criteria:

- Major congenital anomalies.

- Hemodynamic instability requiring inotropes within 72 hours prior to the study

- Culture proven sepsis within 72 hours prior to the study.

- Diagnosis of pulmonary interstitial emphysema or pneumothorax within the 72 hours prior to the study.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms

  • Episodic Hypoxemia in Mechanically Ventilated Preterm Infants.
  • Premature Birth

Intervention

Device:
volume guarantee ventilation
The study will consist of two arms. In one arm, a 24-hour period during which the infant receives conventional mechanical ventilation and a second 24 hour period during which the infant receives volume guarantee ventilation. In the other Arm, a 24-hour period during which the infant receives volume guarantee ventilation and a second 24 hour period during which the infant receives conventional mechanical ventilation. These two arms will be assigned at random. Both conventional and volume guarantee ventilation will be provided by the same neonatal ventilator (AVEA, CareFusion Inc, Yorba Linda, CA). During the 24 hour period of conventional ventilation, the infant will receive mechanical ventilation with the settings determined by the clinical team. During volume guarantee ventilation, the set tidal volume to be maintained by the ventilator will be the average tidal volume delivered by the ventilator prior to start of study.

Locations

Country Name City State
United States Newborn Intensitve Care Unit at Holtz Children's Hospital of Jackson Health System Miami Florida

Sponsors (1)

Lead Sponsor Collaborator
University of Miami

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other The mean and variability in FiO2 recorded data during each of the 24 hour periods. This will include Fraction of inspired oxygen The mean and variability in in the fraction of inspired oxygen (FiO2).This will include the hourly-mean FiO2. 24 hours No
Other Tidal volume The mean and variability in tidal volume (VT) will be calculated. This will include the proportion of mechanical breaths with VT < 3 and < 1.5 ml/Kg. 24 hours No
Other Minute ventilation The mean and variability in total, mechanical and spontaneous minute ventilation will be calculated. 24 hours No
Primary Proportion of time spent with arterial oxygen saturation < 75% Proportion of time spent with arterial oxygen saturation < 75% 24 hours No
Secondary hypoxemia episodes Number, frequency, mean duration and severity of hypoxemia episodes. Hypoxemic episodes will be defined as periods with arterial oxygen saturation SpO2) < 88% and < 75%. 24 hours No